tretazicar has been researched along with Triple Negative Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachawal, SV; Barghava-Shah, A; Devulapally, R; Foygel, K; Lee, T; Paulmurugan, R; Sekar, TV; Willmann, JK | 1 |
| Foygel, K; Ilovich, O; Paulmurugan, R; Sekar, TV | 1 |
2 other study(ies) available for tretazicar and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy.
Topics: Animals; Apoptosis; Aziridines; Cell Line, Tumor; Female; Flow Cytometry; Humans; Lactates; Mice; Mice, Nude; Nanoparticles; Nitroreductases; Polyethylene Glycols; Thymidine Kinase; Transfection; Triple Negative Breast Neoplasms; Ultrasonic Waves | 2018 |
Noninvasive theranostic imaging of HSV1-sr39TK-NTR/GCV-CB1954 dual-prodrug therapy in metastatic lung lesions of MDA-MB-231 triple negative breast cancer in mice.
Topics: Animals; Antineoplastic Agents; Aziridines; Disease Models, Animal; Genetic Therapy; Glutamine; Lung Neoplasms; Mice; Neoplasm Metastasis; Nitroreductases; Optical Imaging; Organometallic Compounds; Prodrugs; Radiography; Thymidine Kinase; Treatment Outcome; Triple Negative Breast Neoplasms | 2014 |